EU5 Gastric Bands and Balloons Market to Reach USD 1.3 Billion by 2034 at 7.8% CAGR

Introduction
Obesity is one of the most pressing public health challenges in Europe, with increasing rates of related comorbidities such as diabetes, cardiovascular diseases, and sleep apnea. As healthcare systems in the EU5 countries (France, Germany, Italy, Spain, and the UK) focus on weight management and preventive care, the demand for effective, minimally invasive obesity treatments is growing. Gastric bands and balloons, both non-surgical interventions for weight loss, have gained popularity as effective alternatives to more invasive bariatric surgeries.

These devices help reduce stomach capacity and promote early satiety, making them key tools in addressing obesity and its associated health risks. With advances in device technology and greater patient acceptance, the EU5 Gastric Bands and Balloons Market is positioned for strong growth over the next decade.

Download Full PDF Sample Copy of Market Report @
https://exactitudeconsultancy.com/request-sample/72332

Market Overview
According to Exactitude Consultancy, the EU5 Gastric Bands and Balloons Market was valued at USD 650 million in 2024 and is projected to reach USD 1.3 billion by 2034, growing at a CAGR of 7.8% during the forecast period.

Key Highlights
• Rising obesity rates and an aging population in the EU5 region are driving demand for non-surgical weight-loss options.
• Gastric balloons are becoming increasingly popular due to their minimally invasive nature, with devices like swallowable balloons seeing significant adoption.
• Advances in biocompatible materials and adjustable balloon technologies are improving patient outcomes and device effectiveness.
• Favorable reimbursement policies in countries like Germany and the UK are boosting device adoption.
• Key challenges include the high cost of devices and the risk of complications such as balloon deflation and gastric ulcers.

Leading Players in the EU5 Gastric Bands and Balloons Market include Allurion Technologies, Apollo Endosurgery, Medtronic, Ethicon (Johnson & Johnson), and ReShape Lifesciences.

Segmentation Analysis
By Product
• Gastric Bands
• Gastric Balloons (Single Balloon, Dual Balloon, Adjustable Balloon Systems, Swallowable Balloons)

By Technology
• Endoscopic Gastric Balloon Systems
• Swallowable Balloon Technologies
• Adjustable Balloon Systems
• Gas-Filled Balloons

By Application
• Obesity Management
• Type 2 Diabetes Management
• Metabolic Syndrome & Other Conditions

By End-Use
• Hospitals
• Specialty Weight-Loss Clinics
• Ambulatory Surgical Centers

Segmentation Summary
Gastric balloons are the dominant product segment, with swallowable balloons and adjustable balloon systems gaining popularity due to their convenience and customizable weight-loss treatment. Gastric bands, although still used, are facing a decline in adoption compared to balloon devices due to the latter's lower complication rates and ease of use. Obesity management is the leading application segment, though there is a growing interest in type 2 diabetes management as these devices help with weight loss and glucose control.

Explore Full Report here:
https://exactitudeconsultancy.com/reports/72332/eu5-gastric-bands-and-balloons-market

Regional Insights
France
• The market is growing steadily with increasing awareness of the health risks associated with obesity and a strong preference for non-surgical treatments.
• Gastric balloon usage is rising in both public and private healthcare settings due to favorable reimbursement policies.
• France is also seeing significant medical tourism in bariatric treatments, particularly in Paris and Lyon.
Germany
• The largest market for gastric bands and balloons in the EU5 region, driven by a robust healthcare system and high levels of healthcare expenditure.
• Increasing demand for minimally invasive weight-loss solutions in both urban and rural regions.
• Germany is a leader in the adoption of adjustable gastric balloon systems and swallowable balloons.
Italy
• Growing concern about obesity, especially in the southern regions of Italy, is driving the adoption of gastric balloons.
• Private healthcare clinics are the primary users of gastric devices, although the public system is catching up in urban centers.
• The demand for gastric balloons is expected to outpace that of gastric bands due to lower complication rates and faster recovery times.
Spain
• High levels of obesity, particularly in Catalonia and Andalusia, are boosting the use of gastric balloons and bands.
• The growing adoption of minimally invasive treatments is leading to a shift away from surgical bariatric procedures toward more affordable, non-surgical options.
• Private clinics in Spain are seeing significant uptake in swallowable balloons and other advanced balloon systems.
United Kingdom
• The UK market is characterized by significant healthcare spending and favorable insurance policies for weight-loss treatments.
• Minimally invasive treatments, including adjustable gastric balloons, are experiencing the highest growth due to the increasing preference for outpatient procedures.
• Strong presence of medical tourism in London and other major cities, attracting patients from Europe seeking non-surgical weight-loss treatments.

Regional Summary
Germany remains the largest market for gastric bands and balloons, followed by the UK and France. Spain and Italy are also seeing strong growth, particularly in private healthcare settings, as patient preference shifts toward non-invasive treatments.

Market Dynamics
Growth Drivers
1. Rising obesity rates - Obesity is increasingly recognized as a major public health issue in the EU5 region, leading to higher demand for weight-loss interventions.
2. Growing preference for minimally invasive treatments - Patients are increasingly opting for non-surgical solutions like gastric balloons and bands, which are less invasive and offer quicker recovery times.
3. Technological advancements - Innovations such as swallowable balloons and adjustable systems are making these devices more convenient and effective for patients.
4. Healthcare reimbursement policies - Countries like Germany and the UK offer favorable reimbursement schemes that support the adoption of gastric bands and balloons.

Challenges
• High device costs - The price of advanced gastric balloons, particularly adjustable and swallowable systems, remains high, limiting access in certain regions.
• Complications - While the complication rates for gastric balloons are lower than for traditional surgery, issues such as balloon deflation, gastric ulcers, and discomfort can still occur.
• Limited access - Despite increasing adoption, access to these devices remains limited in rural or low-income areas within the EU5 region.

Latest Trends
• Swallowable balloons are gaining popularity due to their ease of use and reduced discomfort compared to traditional balloon insertion techniques.
• Adjustable gastric balloons are being developed to allow patients to customize their treatment based on individual weight-loss goals.
• AI and digital monitoring are being integrated into weight-loss programs to help track patient progress and improve treatment outcomes.
• Medical tourism for weight-loss surgeries continues to grow, particularly in Spain, Italy, and the UK, with patients seeking affordable, non-surgical weight-loss options.

Get Your Exclusive Offer with up to 10% Discount :
https://exactitudeconsultancy.com/checkout/?currency=USD&type=single_user_license&report_id=72332

Competitor Analysis
Major Players in the Market
• Allurion Technologies
• Apollo Endosurgery
• Medtronic plc
• Ethicon (Johnson & Johnson)
• ReShape Lifesciences
• Obalon Therapeutics
• Spatz Medical
• Fobi Capsule

Competitive Landscape Summary
Allurion Technologies and Apollo Endosurgery are leading the gastric balloon segment with innovative products such as the Allurion Balloon and Apollo Lap-Band. Ethicon (Johnson & Johnson) and Medtronic dominate the gastric band segment, though the demand for these products is decreasing in favor of balloons. The market is also witnessing increasing interest from newer players like ReShape Lifesciences and Obalon Therapeutics, which focus on innovative, non-invasive weight-loss devices.
Key Strategies among market players include product innovation, strategic partnerships with hospitals and clinics, and expanding into emerging markets.

Conclusion
The EU5 Gastric Bands and Balloons Market is projected to grow from USD 650 million in 2024 to USD 1.3 billion by 2034, at a CAGR of 7.8%. Rising obesity rates, an increasing preference for minimally invasive surgeries, and technological advancements will continue to fuel growth in the coming years.

Key Takeaways
• Gastric balloons are set to lead the market, with swallowable and adjustable balloons showing the fastest growth.
• Germany remains the largest market, with strong growth also expected in the UK and France.
• Innovation in product technology and medical tourism are shaping market dynamics.
• Affordability and accessibility will continue to drive success in private clinics and healthcare systems across the EU5.

This report is also available in the following languages : Japanese (EU5 胃バンドおよびバルーン市場), Korean (EU5 위밴드 및 풍선 시장), Chinese (欧盟五国胃束带和胃球囊市场), French (Marché des anneaux et ballons gastriques EU5), German (EU5-Markt für Magenbänder und Ballons), and Italian (Mercato dei nastri e dei palloncini gastrici EU5), etc.

Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @
https://exactitudeconsultancy.com/request-sample/72332

Our More Reports:

Optic Neuritis Market
https://exactitudeconsultancy.com/reports/72238/optic-neuritis-market

Neurotrophic Keratitis Market
https://exactitudeconsultancy.com/reports/72236/neurotrophic-keratitis-market

Myopic Macular Degeneration (MMD) Market
https://exactitudeconsultancy.com/reports/72234/myopic-macular-degeneration-mmd-market

About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/

https://www.thehealthanalytics.com/

https://www.analytica.global/

https://www.marketintelligencedata.com/

https://www.marketinsightsreports.com/

https://exactitudeconsultancy.com/

Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com

This release was published on openPR.